Ultrasound guided pleural biopsy in undiagnosed exudative pleural effusion patients  by Ahmed, Adel S. et al.
Egyptian Journal of Chest Diseases and Tuberculosis (2016) 65, 429–434HO ST E D  BY
The Egyptian Society of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis
www.elsevier.com/locate/ejcdt
www.sciencedirect.comORIGINAL ARTICLEUltrasound guided pleural biopsy in undiagnosed
exudative pleural eﬀusion patients* Corresponding author.
Peer review under responsibility of The Egyptian Society of Chest
Diseases and Tuberculosis.
http://dx.doi.org/10.1016/j.ejcdt.2015.12.012
0422-7638 Crown Copyright  2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and Tube
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Adel S. Ahmed, Mostafa I. Ragab, Alaa eldin M. Elgazaar *, Nagwan A. IsmailChest Department, Faculty of Medicine, Zagazig University, EgyptReceived 10 December 2015; accepted 15 December 2015
Available online 11 January 2016KEYWORDS
Pleural biopsy ultrasound;
CT guided;
ThoracoscopyAbstract Introduction: Pleural biopsy for pathological conﬁrmation is the standard diagnostic
procedure for pleural diseases, transthoracic ultrasonography (TUS) has evolved as an important
imaging tool for diagnosing pleural and pulmonary conditions.
Aim of the study: To assess the diagnostic yield of TUS guided pleural biopsy versus both CT
guided and thoracoscopic pleural biopsy in the diagnosis of undiagnosed exudative pleural effusion.
Patients and methods: The study was conducted at chest department, Zagazig University Hospi-
tals. The study included 60 patients with undiagnosed exudative pleural effusion. They were
assigned randomly (by systematic randomization) after signing an informed consent into three
groups according to the method by which pleural biopsy was obtained (Group A, TUS guided
biopsy group, Group B, CT guided pleural biopsy, Group C, MT pleural biopsy) each included
20 patients.
Results: The mean age of the studied patients was 52 ± 10.3 years; they were 27 females and 33
males with no statistical signiﬁcance. There was no statistical signiﬁcance between the 3 studied
groups regarding, co-morbidities, side of effusion, smoking pattern, and pleural ﬂuid parameters
except pleural ﬂuid WBCs (was higher in group B). Malignancy was the most common etiology
in 48/60 patients (80%). The diagnostic yield of TUS guided pleural biopsy was 80% versus
85% for CT guided pleural biopsy and 92.5% for thoracoscopic pleural biopsy. Reported compli-
cations were (for TUS guided pleural biopsy were; pain in 90% of patients, pneumothorax 5%,
hemoptysis 35%, biopsy site bleeding 20% and shock in 15%), (for CT guided biopsy; pain in
100% of patients, pneumothorax 15%, hemoptysis 50%, biopsy site bleeding 60% and shock in
10%), and (for medical thoracoscopy; intra-operative bleeding 3.7%, broncho-pleural ﬁstula
7.4%, failure of lung expansion 14.8%, surgical emphysema 18.5%, post-operative empyema
3.7%). MT was superior in the detection of pleural septations and visceral pleural nodules; the inci-
dence of complication was correlated to the length of the procedure time in MT group.rculosis.
430 A.S. Ahmed et al.In conclusion: Thoracic ultrasound (TUS) guided pleural biopsy had a diagnostic yield which
was slightly lower but comparable to both CT guided pleural biopsy and medical thoracoscopic
pleural biopsy (MT).
Crown Copyright  2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of
Chest Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pleural biopsy for histologic conﬁrmation is the standard
diagnostic procedure for pleural diseases. The pleural involve-
ment by tuberculosis or by a malignancy is not uniform.
The result of a blind closed biopsy without any guidance
may not be diagnostic [1]. Transthoracic ultrasonography
(TUS) has evolved as an important imaging technique for
diagnosing pleural and pulmonary conditions [2]. Ultra-
sonography may detect abnormal areas of the pleura that
may be targeted for biopsy. Yield is improved with this
approach when compared with random pleural sampling. [3].
Thoracoscopy remains the most efﬁcient and the gold
standard; however cost-effective approach to the diagnosis of
pleural exudates, it allows for the direct inspection of the
pleura and biopsies taken under direct vision, and has a diag-
nostic yield of 91–95% for malignant disease and as high as
100% for pleural tuberculosis [4].
Aim of the study
To assess the diagnostic yield of TUS guided pleural biopsy
versus both CT guided and thoracoscopic pleural biopsy in
the diagnosis of exudative pleural effusion.
Patients and methods
Study design
Observational prospective clinical comparative study.
The study was conducted at chest department, Zagazig
University Hospitals in the period from January 2013 to June
2015. The study included 60 patients with undiagnosed exuda-
tive pleural effusion.
Tools and instruments used for data collection included:
1. Thorough medical history.
2. Full clinical examination including: General and local
examination.
3. Radiological investigations:
(a) Plain chest X-ray (P.A & lateral views); was done
before & after any pleural intervention to exclude
complications.
(b) Pelvi-abdominal ultrasound and contrast enhanced
CT to exclude abdominal malignancy.
4. Routine hematological investigations:
(a) CBC, ESR, Liver function tests, Kidney function
tests, bleeding proﬁle, BT, PTT, PC.
(b) Fasting and two hours post prandial blood glucose,
simultaneous with measurement of pleural ﬂuid glu-
cose level.5. Speciﬁc and pleural ﬂuid investigations:
(c) Serum total protein, LDH simultaneous with mea-
surement of pleural ﬂuid values.
(d) Serological analysis. Serum rheumatoid factor (RF).
 Serum antinuclear antibody (ANA).
 Cytological examination for malignant cells, ade-
nosine deaminase (ADA), rheumatoid factor.Patient enrollment in the study
Patients with exudative pleural effusion who fail to be diag-
nosed by the previously mentioned conventional methods,
after signing an informed consent were assigned according to
the method by which pleural biopsy was obtained into three
groups (A, B, C). They were assigned randomly (by systematic
random methods, the ﬁrst patient underwent US guided pleu-
ral biopsy; next patient CT guided pleural biopsy, and the
third patient thoracoscopic pleural biopsy and so on). Patients
who failed to reach ﬁnal diagnosis by TUS or CT guided
biopsy were referred to medical thoracoscopy group and man-
aged accordingly.
Group A: 20 Patients with exudative pleural effusion for
whom Chest US guided pleural biopsy was done (Samsung,
Medison Sono, Ace R3, ultrasound system, Korea) using
18-gauge needle of 20 cm length (TSKUROCUT biopsy needle).
Group B: 20 Patients with exudative pleural effusion for
whom CT guided pleural biopsy was done. Scan was done
using multi-slice CT scanner (General Electric, Milwaukee,
USA). After identiﬁcation of the maximum area of pleural
thickening, under aseptic technique and local anesthesia, an
18-gauge needle of 20 cm length (TSK UROCUT biopsy nee-
dle. Japan) was inserted tangentially and closed until the area
of maximum thickness of the parietal pleura is reached, then
opened to gain an adequate core of pleural tissue.
Group C: 27 Patients with exudative pleural effusion for
whom medical thoracoscopic guided pleural biopsy was done
(karl Storz LTD, Germany), 20 patients plus 4 patients who
failed to be diagnosed by US guided biopsy and 3 patients
who failed to be diagnosed by CT guided biopsy. Inspection
of the pleural cavity, biopsy and electrocoagulation of any
resultant serious bleeding was done. Pre-thoracoscopic chest
US was done for the detection of any encystment or pleural
thickening before procedure.
End point of the study
To reach ﬁnal diagnosis by any of the previous method
patients, i.e. who were undiagnosed by US guided pleural
biopsy (Group A) or CT guided pleural biopsy (Group B),
Table 1 Demographic data of the studied patients.
Variable Group A (No. 20) Group B (No. 20) Group C (No. 20) Test
F test
P value
Age (years)
 Range
 (Mean ± SD)
23–58
49.15 ± 16.4
26–55
55.85 ± 10.3
22–57
50.5 ± 16.08
49.15 ± 16.4 1.18 0.31
No. % No. % No. % v2
Gender
 Female
 Male
7
13
35
65
11
9
55
45
9
11
45
55
1.6 0.44
No co morbidities: 12 60 19 95 7 35
Co-morbidities:
 HTN
 DM
 CA
 Hepatic
1
4
0
3
5
20
0
10
0
1
0
0
0
5
0
0
3
6
3
1
15
30
10
5
29.037 0.11
Side of eﬀusion
 Isolated RT
 Isolated LT
 Bilateral
10
10
0
50
50
0
8
10
2
40
50
10
9
8
3
45
40
15
12.34 0.13
Smoking pattern
 Current
 Ex-smoker
 Non-smoker
13
2
5
60
10
30
10
4
6
50
20
30
15
0
5
75
0
15
10.72 0.097
Ultrasound guided pleural biopsy 431were referred to thoracoscopy group (Group C) to get the
chance for ﬁnal diagnosis.
Results
The study included 60 patients with exudative pleural effusion;
27 females and 33 males, 38 patients who were current smoker,
6 patients ex-smoker and 16 patients were non-smoker. The
mean age was 52 ± 10.3 years; there were 38 patients with
no co-morbidities however 22 patients had co-morbidities in
the form of 4 hypertensive patients, 11 diabetic patients, 3
patients with past history of cancer and 4 hepatic patients.
Twenty-seven patients were with RT sided pleural effusion,
28 patients with left sided pleural effusion and 5 patients with
bilateral pleural effusion Table 1. There was no statistically
signiﬁcant difference between groups regarding pleural ﬂuid
parameters (P 0.38) except WBC count which was higher in
the CT guided biopsy group (p 0.03).Table 2 Etiological diagnosis among studied groups.
Diseases Inﬂammatory Malignancy
TB CTD Iry pleural Hematologic
Group A (20)
No 1 4 3 1
% 5% 20% 15% 5%
Group B (20)
No 0 1 6 3
% 0% 5% 30% 15%
Group C (27)
No 1 3 8 5
% 3.7% 11.11% 29.62% 18.5%Final etiological diagnosis
The etiological diagnosis of the studied patients: 48 patients
(80%) were of malignant etiology: [17 patients with Iry pleural
malignancy (28.3%), 9 patients with hematological malig-
nancy: (15%), 22 patients with metastatic carcinoma
(36.6%)] while 10 patients (16.6%) showed inﬂammatory
pathology [2 patients with TB (3.3%), 8 patients with CTD
(13.3%)] and 2 patients remained undiagnosed even after tho-
racoscopic. Table 2.
Diagnostic yield of the three studied modalities
TUS was diagnostic in 80% of patients, CT guided pleural
biopsy was diagnostic in 85% of cases, while thoracoscopic
pleural biopsy was diagnostic in 92.5% of cases without statis-
tical signiﬁcance (p 0.45) Table 3.Non-diagnosed X2 P value
al Metastatic
7.41 0.11
7 4
35% 20%
7 3
35% 15%
8 2
29.62% 7.4%
Table 3 Diagnostic yield among studied groups.
Diagnostic yield TUS guided (total no. = 20) CT guided (total no. = 20) Thoracoscopy (total no. = 27) P value
+ve 16(80%) 17 (85%) 25 (92.5%) 0.45
ve% 4 (20%) 3 (15%) 2 (7.5%)
Total 20 (100%) 20 (100%) 27 (100%)
Table 4 Complications of medical thoracoscopy.
Complications Total No.
(27)
Duration of procedure
No. % Within range
(20–30 min.)
Prolonged
(45–55 min.)
Intra-operative
bleeding
1 3.7 0 1
Bronchopleural
ﬁstula
2 7.4 1 1
Failure of full
lung expansion
4 14.8 1 3
Surgical
emphysema
5 18.5 1 4
Post-operative
empyema
1 3.7 0 1
No complications 14 51.85 13 1
Table 5 Complications of image guided pleural biopsy (CT,
TUS).
Complications TUS
guided
biopsy (20
patient)
CT guided
biopsy (20
patient)
X2 P value
No. % No. %
Pain 18 90 20 100 2.7 0.6
Pneumothorax 1 5 3 15
Haemoptysis 7 35 10 50
Bleeding at biopsy site 4 20 12 60
Shock 3 15 2 10
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Complications of medical thoracoscopy were intra-operative
bleeding |(one patient), broncho-pleural ﬁstula (2 patients),
failure of lung expansion (4 patients, 3 of those patients had
longer duration of the procedure), surgical emphysema (5
patients, 4 of those patients had longer duration of the proce-
dure), and one patient developed post-operative empyema, 14
patients developed no complications Table 4.
Complications of image guided pleural biopsy
Procedure related Pain was reported in 18 patients (90%) in
TUS guided pleural biopsy group Vs 20 patients (100%) in
CT guided pleural biopsy group, 1 patient (5%) developed
pneumothorax in TUS Vs 3 patients (15%) in CT, 7 patients
(35%) developed hemoptysis in TUS Vs 10 patients (50%) in
CT, 4 patients (20%) suffered from bleeding from biopsy site
in TUS Vs 12 patients (60%) in CT and 3 patients (15%) suf-
fered from post-procedural shock in TUS Vs 2 patients (10%)
in CT with no statistically signiﬁcant difference between both
procedures. Table 5.
Discussion
Undiagnosed pleural effusions represent an increasing diag-
nostic burden upon healthcare providers internationally. The
investigation of pleural effusions often requires the acquisition
of tissue for histological analysis and diagnosis. Historically
there were two options for tissue biopsy: a ‘gold standard’ sur-
gical biopsy or a ‘‘blind” closed pleural biopsy. Over the last
decade however, image-guided Tru-cut biopsies and local tho-racoscopic biopsies have become more widespread Dixon et al.
[5]. Image-guided techniques acquire samples under ultrasound
(US) or computed tomography (CT) guidance whereas MT
involves the direct visualization and biopsy of the pleura.
The introduction of US into the thoracic medicine and its
availability as a bedside, cheap and its association with mini-
mal complications motivated the present study to assess its
diagnostic yield and complications versus both CT guided
and thoracoscopic pleural biopsy.
This study was carried out on Sixty patients with exudative
pleural effusion in whom routine and speciﬁc pleural ﬂuid
analysis were not diagnostic, their mean age was 52
± 10.3 years. Malignancy was the most common etiology
among the studied patients in the three groups 48/60 (80%)
whether primary pleural or metastatic; this was consistent with
the ﬁndings of Mohamed et al. [10], Selim et al. [8], Prabhu and
Narasimhan [7] and Sudheer et al. [6] where they studied
patients with undiagnosed pleural effusion and most of their
patients were within the mean age group. While in the study
of Nithya and Suraj [14], the mean age was slightly lower than
that found in the present study (43.04 ± 10.05 years), where
the dominant etiologies in their study were tuberculosis, and
pneumonia, while malignancies was the third.
In the present study, TUS guided pleural biopsy was diag-
nostic in 16 patients out of 20 patients with 80% diagnostic
accuracy; those 16 patients were, 11 patients with pleural
malignancy, 4 patients with connective tissue disorders, one
patient with tuberculous effusion. CT guided pleural biopsy
was diagnostic in 85% (17 patients out of 20 patients while
medical thoracoscopy (MT) was diagnostic in 92.5% of cases
(25 patients out of 27)) (Table 3). In the present study TUS
was the lowest diagnostic yield among the three studied modal-
ities. This could be attributed to the random allocation of
patients in the study groups directly affected the diagnostic
yield of US group of patients since pleural thickening which
is favorable to US was present only in 3 patients Vs 8 patients
in the CT guided group and 5 in the MT group.
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with no radiation risk for the patient, cheap, readily accessible,
and well tolerated, no need for sedation and the procedure is
carried out as a day case where discharge is possible after brief
observation Giles et al. [15]. In comparison to CT guided
biopsy which is usually performed by a trained and experi-
enced radiologist and the medical thoracoscopy which is usu-
ally done under direct vision, TUS had shown the lowest but
accepted diagnostic yield in the present study (80% Vs 85%
for CT guided biopsy and 92.5% for MT) without a statistical
signiﬁcance (p= 0.45) (Table 5).
Glies et al. [15], reviewed multiple studies and reported a
diagnostic yield of TUS 77%, 83% for CT guided biopsy
and 92.6% for medical thoracoscopy, Matthew et al. [9]
reported a diagnostic yield of 81% for TUS guided pleural
biopsy Vs 100% for MT, Mohamed et al. [10] reported a diag-
nostic yield of TUS guided pleural biopsy (75%) Vs (100%)
for MT and Qureshi et al. [11], reported a diagnostic yield of
86.5% for TUS guided pleural biopsy Vs 97% for CT guided
pleural biopsy. All the previously mentioned studies reported
comparable results to the ﬁnding of the present study.
On the other hand higher diagnostic yield of TUS was
reported by Sconﬁenza et al. [13] (97% for TUS guided biopsy
Vs 96.5% for CT guided biopsy) and Hallifax et al. [12]
reported a diagnostic yield of 94% for TUS guided pleural
biopsy Vs 100% for MT. The higher yield of US in the study
of Sconﬁenza et al. [13] could be attributed to patient selection
in the study where most selected patients had had pleural
lesions (31 patients) and peripherally located pulmonary
lesions (72 patients).
Regarding complications reported in the present study; in
the medical thoracoscopy group; 14 patients out of 27 patients
developed no complications (51.85%). However; the most
commonly encountered complication was surgical emphysema
in 5 patients (18.5%) followed by failure of lung expansion in 4
patients (14.8%), 2 patients developed broncho-pleural ﬁstula
(7.4%), one patient developed intra-operative bleeding (3.7%),
and one patient developed empyema (3.7%) (Table 4).
Most complication occurred in patients in whom the proce-
dure was prolonged more than 30 min and a positive correla-
tion was found in the present study between the time of the
procedure and the development of complications (r= 0.36,
p= 0.06).
The development of surgical emphysema is a common com-
plication of thoracotomy and intercostals tube insertion even
with minimal manipulation and its occurrence with MT may
be higher due to excessive manipulations which are more trau-
matizing to the chest wall structures including the skin and
subcutaneous tissues and intercostals muscles. Higher inci-
dence of surgical was reported by Hosny et al., 2013 during
medical thoracoscopy where surgical emphysema occurred in
14/40 patients (35%)
Regarding complications of TUS and CT guided pleural
biopsy in the present study although chest pain was higher in
CT than in TUS 20/20 patients (100%) VS 18/20 patients
(90%), bleeding at biopsy site 12/20 patients in CT (60%) Vs
4 patients in TUS (20%), hemoptysis 10/20 patients (50%) in
CT Vs 7/20 patients (35%) in TUS, pneumothorax in 3/20
patients (15%) Vs 1/20 patients in TUS (5%), and shock
2/20 patients in CT (10%) Vs 3/20 patients in TUS (15%)
but without statistical signiﬁcance (p = 0.6). Similar ﬁndings
were reported by Glies et al. [15] who reported that TUSguided pleural biopsy developed mild hemoptysis in (19%).
Sconﬁenza et al. [13] reported post TUS pneumothorax in
5.8%. Glies et al. [15] CT guided biopsy developed complica-
tions in the form of pneumothorax in 2% and bleeding at
the site of biopsy in 7.5%. Sconﬁenza et al. [13] showed CT
guided biopsy developed post procedural pneumothorax in
14.7% and hemothorax in 1.2%. In conclusion, Thoracic
ultrasound (TUS) guided pleural biopsy is a safe procedure,
with a diagnostic yield which was slightly lower but compara-
ble to both CT guided pleural biopsy and medical thoraco-
scopic pleural biopsy (MT). When done prior to medical
thoracoscopy, it can detect thick ﬁbrous septations and multi-
loculation. Alert the thoracoscopist to the likely presence of
thick ﬁbrous adhesions which may prolong the procedure
and impede lung expansion.
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